Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs

Physicians often continue to prescribe brand-name drugs to their patients even when less expensive generic equivalents are available. In a 1994 study, Judith Hellerstein advances two hypotheses to explain this behavior. First, doctors may consciously conclude that certain brand-name drugs impart a r...

Full description

Bibliographic Details
Main Author: Howard, Robert E.
Other Authors: Economics
Format: Others
Published: Virginia Tech 2014
Subjects:
Online Access:http://hdl.handle.net/10919/30558
http://scholar.lib.vt.edu/theses/available/etd-504320749731261/
id ndltd-VTETD-oai-vtechworks.lib.vt.edu-10919-30558
record_format oai_dc
spelling ndltd-VTETD-oai-vtechworks.lib.vt.edu-10919-305582020-09-29T05:46:28Z Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs Howard, Robert E. Economics Wentzler, Nancy A. Reid, Brian K. Porter, William R. generic drugs physician behavior generic substitution perscription drug prices Physicians often continue to prescribe brand-name drugs to their patients even when less expensive generic equivalents are available. In a 1994 study, Judith Hellerstein advances two hypotheses to explain this behavior. First, doctors may consciously conclude that certain brand-name drugs impart a relative therapeutic benefit that outweighs their higher cost. Second, physicians may choose to prescribe brand-name drugs without evidence of therapeutic superiority if neither they nor their insured patients bear the increased cost of these drugs. The second hypothesis implies that moral hazard is evident in physicians' prescribing behavior. Hellerstein's findings support neither hypothesis, but her estimation equation does not explicitly capture the effects of brand-name/generic price differentials and information diffusion on the probability of generic prescription. The author adapts Hellerstein's theoretical model to a modified estimation equation that incorporates these effects and uses it to create new estimates based on data on antimicrobial prescriptions from the 1994 National Ambulatory Medical Care Survey (NAMCS). Unexpectedly, the results appear to affirm both hypotheses. The evidence for moral hazard is particularly strong, as self-paying patients are significantly more likely than patients with Medicare or private insurance to be prescribed the generics that are cheapest relative to their brand-name counterparts. The author also finds that certain popular antimicrobial drugs such as amoxicillin and sulfamethoxazole/trimethoprim are prescribed in the same form (generic or brand-name) by most doctors to most patients. The market power exhibited by these preferred forms leads the author to conclude that they are "brands" in the economic sense. Master of Arts 2014-03-14T20:22:03Z 2014-03-14T20:22:03Z 1997-04-24 1998-07-13 1997-04-24 1997-04-24 Thesis etd-504320749731261 http://hdl.handle.net/10919/30558 http://scholar.lib.vt.edu/theses/available/etd-504320749731261/ etd.pdf In Copyright http://rightsstatements.org/vocab/InC/1.0/ application/pdf Virginia Tech
collection NDLTD
format Others
sources NDLTD
topic generic drugs
physician behavior
generic substitution
perscription drug prices
spellingShingle generic drugs
physician behavior
generic substitution
perscription drug prices
Howard, Robert E.
Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
description Physicians often continue to prescribe brand-name drugs to their patients even when less expensive generic equivalents are available. In a 1994 study, Judith Hellerstein advances two hypotheses to explain this behavior. First, doctors may consciously conclude that certain brand-name drugs impart a relative therapeutic benefit that outweighs their higher cost. Second, physicians may choose to prescribe brand-name drugs without evidence of therapeutic superiority if neither they nor their insured patients bear the increased cost of these drugs. The second hypothesis implies that moral hazard is evident in physicians' prescribing behavior. Hellerstein's findings support neither hypothesis, but her estimation equation does not explicitly capture the effects of brand-name/generic price differentials and information diffusion on the probability of generic prescription. The author adapts Hellerstein's theoretical model to a modified estimation equation that incorporates these effects and uses it to create new estimates based on data on antimicrobial prescriptions from the 1994 National Ambulatory Medical Care Survey (NAMCS). Unexpectedly, the results appear to affirm both hypotheses. The evidence for moral hazard is particularly strong, as self-paying patients are significantly more likely than patients with Medicare or private insurance to be prescribed the generics that are cheapest relative to their brand-name counterparts. The author also finds that certain popular antimicrobial drugs such as amoxicillin and sulfamethoxazole/trimethoprim are prescribed in the same form (generic or brand-name) by most doctors to most patients. The market power exhibited by these preferred forms leads the author to conclude that they are "brands" in the economic sense. === Master of Arts
author2 Economics
author_facet Economics
Howard, Robert E.
author Howard, Robert E.
author_sort Howard, Robert E.
title Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
title_short Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
title_full Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
title_fullStr Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
title_full_unstemmed Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
title_sort factors influencing physicians' willingness to substitute generics for brand-names when prescribing antimicrobial drugs
publisher Virginia Tech
publishDate 2014
url http://hdl.handle.net/10919/30558
http://scholar.lib.vt.edu/theses/available/etd-504320749731261/
work_keys_str_mv AT howardroberte factorsinfluencingphysicianswillingnesstosubstitutegenericsforbrandnameswhenprescribingantimicrobialdrugs
_version_ 1719345991497285632